Holistic Management of Patients with Progressive Pulmonary Fibrosis

Overview

Journal Breathe (Sheff)

Specialty Pulmonary Medicine

Date 2023 Sep 18

PMID 37719243

Authors

Ana Oliveira

Gaia Fabbri

Thomas Gille

Elena Bargagli

Boris Duchemann

Rachel Evans

Hilary Pinnock

Anne E Holland

Elisabetta Renzoni

Magnus Ekstrom

Steve Jones

Marlies Wijsenbeek

Anh Tuan Dinh-Xuan

Guido Vagheggini

Affiliations

Soon will be listed here.

Abstract

Educational Aims: To identify the main needs of patients with PF and their caregivers.To describe the components of a comprehensive approach to a supportive care programme for patients with PF.To identify further areas of research to address technical issues related to the management of patients with PF.

Citing Articles

Quality of life in idiopathic pulmonary fibrosis in Latin American countries.

Aguilar-Duran H, Fernandez M, Gonzalez-Garcia M, Rincon-Alvarez E, Alberti M, Caro F BMC Pulm Med. 2025; 25(1):36.

PMID: 39856586 PMC: 11759421. DOI: 10.1186/s12890-025-03506-2.

Referral to pulmonary rehabilitation and palliative care services in people with idiopathic pulmonary fibrosis in England, 2010-2019.

Morgan A, Khan H, George P, Quint J NPJ Prim Care Respir Med. 2024; 34(1):27.

PMID: 39384815 PMC: 11464758. DOI: 10.1038/s41533-024-00387-6.

High-Risk Sarcoidosis: A Focus on Pulmonary, Cardiac, Hepatic and Renal Advanced Diseases, as Well as on Calcium Metabolism Abnormalities.

Israel-Biet D, Bernardinello N, Pastre J, Tana C, Spagnolo P Diagnostics (Basel). 2024; 14(4).

PMID: 38396434 PMC: 10887913. DOI: 10.3390/diagnostics14040395.

The changing face of the modern respiratory clinician.

Kent B Breathe (Sheff). 2023; 19(3):230147.

PMID: 37732949 PMC: 10501710. DOI: 10.1183/20734735.0147-2023.

References

Barratt S, Morales M, Speirs T, Al Jboor K, Lamb H, Mulholland S . Specialist palliative care, psychology, interstitial lung disease (ILD) multidisciplinary team meeting: a novel model to address palliative care needs. BMJ Open Respir Res. 2019; 5(1):e000360. PMC: 6307575. DOI: 10.1136/bmjresp-2018-000360. View

Maher T, Schiffman C, Kreuter M, Moor C, Nathan S, Axmann J . A review of the challenges, learnings and future directions of home handheld spirometry in interstitial lung disease. Respir Res. 2022; 23(1):307. PMC: 9651119. DOI: 10.1186/s12931-022-02221-4. View

Du Plessis J, Fernandes S, Jamal R, Camp P, Johannson K, Schaeffer M . Exertional hypoxemia is more severe in fibrotic interstitial lung disease than in COPD. Respirology. 2017; 23(4):392-398. DOI: 10.1111/resp.13226. View

Cassidy N, Fox L, Love M, Byrne I, Doyle A, Korn B . Fibrotic interstitial lung disease - palliative care needs: a World-Café qualitative study. BMJ Support Palliat Care. 2021; 14(e3):e2649-e2656. PMC: 11672070. DOI: 10.1136/bmjspcare-2021-003249. View

Glaspole I, Chapman S, Cooper W, Ellis S, Goh N, Hopkins P . Health-related quality of life in idiopathic pulmonary fibrosis: Data from the Australian IPF Registry. Respirology. 2017; 22(5):950-956. DOI: 10.1111/resp.12989. View

Cerdan-De-Las-Heras J, Balbino F, Lokke A, Catalan-Matamoros D, Hilberg O, Bendstrup E . Tele-Rehabilitation Program in Idiopathic Pulmonary Fibrosis-A Single-Center Randomized Trial. Int J Environ Res Public Health. 2021; 18(19). PMC: 8508000. DOI: 10.3390/ijerph181910016. View

van Boven J, Drummond D, Chan A, Hew M, Hui C, Adejumo I . ERS "CONNECT" Clinical Research Collaboration - moving multiple digital innovations towards connected respiratory care: addressing the over-arching challenges of whole systems implementation. Eur Respir J. 2023; 62(5). DOI: 10.1183/13993003.01680-2023. View

Ilicic A, Oliveira A, Habash R, Kang Y, Kho M, Goldstein R . Non-pharmacological Management of Non-productive Chronic Cough in Adults: A Systematic Review. Front Rehabil Sci. 2022; 3:905257. PMC: 9397766. DOI: 10.3389/fresc.2022.905257. View

Wickerson L, Helm D, Gottesman C, Rozenberg D, Singer L, Keshavjee S . Telerehabilitation for Lung Transplant Candidates and Recipients During the COVID-19 Pandemic: Program Evaluation. JMIR Mhealth Uhealth. 2021; 9(6):e28708. PMC: 8213059. DOI: 10.2196/28708. View

10.

Schaeffer M, Ryerson C, Ramsook A, Molgat-Seon Y, Wilkie S, Dhillon S . Effects of hyperoxia on dyspnoea and exercise endurance in fibrotic interstitial lung disease. Eur Respir J. 2017; 49(5). DOI: 10.1183/13993003.02494-2016. View

11.

Birring S, Kavanagh J, Irwin R, Keogh K, Lim K, Ryu J . Treatment of Interstitial Lung Disease Associated Cough: CHEST Guideline and Expert Panel Report. Chest. 2018; 154(4):904-917. DOI: 10.1016/j.chest.2018.06.038. View

12.

Harrison A, Robinson J, Tu L, McDonald C, Khor Y . Multidisciplinary Care and Prognosis in Patients With COPD and Interstitial Lung Disease Prescribed Long-Term Oxygen Therapy. Respir Care. 2022; 67(6):667-675. DOI: 10.4187/respcare.09446. View

13.

Khor Y, Gutman L, Abu Hussein N, Johannson K, Glaspole I, Guler S . Incidence and Prognostic Significance of Hypoxemia in Fibrotic Interstitial Lung Disease: An International Cohort Study. Chest. 2021; 160(3):994-1005. DOI: 10.1016/j.chest.2021.04.037. View

14.

Cheng J, Wilcox P, Glaspole I, Corte T, Murphy D, Hague C . Cough is less common and less severe in systemic sclerosis-associated interstitial lung disease compared to other fibrotic interstitial lung diseases. Respirology. 2017; 22(8):1592-1597. DOI: 10.1111/resp.13084. View

15.

Moor C, Mostard R, Grutters J, Bresser P, Aerts J, Chavannes N . Home Monitoring in Patients with Idiopathic Pulmonary Fibrosis. A Randomized Controlled Trial. Am J Respir Crit Care Med. 2020; 202(3):393-401. DOI: 10.1164/rccm.202002-0328OC. View

16.

Wijsenbeek M, Holland A, Swigris J, Renzoni E . Comprehensive Supportive Care for Patients with Fibrosing Interstitial Lung Disease. Am J Respir Crit Care Med. 2019; 200(2):152-159. DOI: 10.1164/rccm.201903-0614PP. View

17.

Russell A, Adamali H, Molyneaux P, Lukey P, Marshall R, Renzoni E . Daily Home Spirometry: An Effective Tool for Detecting Progression in Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2016; 194(8):989-997. PMC: 5067818. DOI: 10.1164/rccm.201511-2152OC. View

18.

Almond H . Patient support groups are a lifeline for those with idiopathic pulmonary fibrosis. Lancet Respir Med. 2020; 8(10):959-961. DOI: 10.1016/S2213-2600(20)30067-9. View

19.

Tikellis G, Corte T, Teoh A, Glaspole I, Macansh S, Holland A . Barriers and facilitators to best care for idiopathic pulmonary fibrosis in Australia. Respirology. 2021; 27(1):76-84. DOI: 10.1111/resp.14185. View

20.

Noth I, Cottin V, Chaudhuri N, Corte T, Johannson K, Wijsenbeek M . Home spirometry in patients with idiopathic pulmonary fibrosis: data from the INMARK trial. Eur Respir J. 2021; 58(1). PMC: 8264778. DOI: 10.1183/13993003.01518-2020. View